Related Experiment Video For Chemotherapy
Updated: Jan 15, 2026
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
Construction of the central symptom cluster management program for patients with lung cancer undergoing chemotherapy:
Le Zhang1, Yuanyuan Luo1, Dongmei Mao1
1School of Nursing, Southern Medical University, Guangzhou, Guangdong, 510515, China.
Background:
In recent years, the incidence of cancer has been on the rise worldwide due to environmental pollution, poor lifestyle habits, and increasing medical diagnoses. In China, the incidence and mortality of lung cancer both rank first among malignant tumors. In the process of cancer diagnosis and treatment, patients with lung cancer undergoing chemotherapy experience a serious symptom burden. Inadequate symptom management will aggravate the physical and mental pain of patients and even delay or interrupt the treatment of the disease. Therefore, it is urgent to provide symptom management programs for medical staff and patients with lung cancer undergoing chemotherapy.
Objective:
To construct the central symptom cluster management program for patients with lung cancer undergoing chemotherapy (CSCMP).
Methods:
Under the guidance of Symptom Management Theory (SMT), the draft program was formed in December 2023 through the clinical expert meeting based on the best evidence summary, and the final program was formed after two rounds of Delphi with 17 experts between December 2023 and March 2024. Descriptive statistics and consistency tests (Kendall's W) were used to analyze the data.
Results:
The final program consists of 12 items in 7 different dimensions. The 7 dimensions are intervention symptom, intervention method, intervention time, intervention content, intervention personnel, intervention place, and intervention form. The 12 items include intervention training, focus assessment, health guidance, diet nursing, psychological nursing, exercise intervention, Traditional Chinese Medicine (TCM) intervention, energy-saving skills, life nursing, environmental nursing, sleep hygiene, and follow-up. In both rounds of Delphi, the recovery rate (RR) was 100%, the expert authority coefficient (Cr) was 0.888, the coefficient of variation (CV) was 0.130-0.280 and 0.110-0.197, respectively, the Kendall's W was 0.467 and 0.523, respectively, and P < 0.05.
Conclusion:
CSCMP established in this study is scientific and credible, has clinical operability, and can guide medical staff and patients with lung cancer undergoing chemotherapy to carry out symptom management in complex clinical environments.
Related Concept Videos
01:30Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
01:29Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
01:26COPD: Management Using Bronchodilators and Corticosteroids